CD40 Chromosome 20
CD40 molecule
Upload your DNA to see your personal genotypes for variants in CD40.
What This Gene Does
This gene is a member of the TNF-receptor superfamily. The encoded protein is a receptor on antigen-presenting cells of the immune system and is essential for mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. AT-hook transcription factor AKNA is reported to coordinately regulate the expression of this receptor and its ligand, which may be important for homotypic cell interactions. Adaptor protein TNFR2 interacts with this receptor and serves as a mediator of the signal transduction. The interaction of this receptor and its ligand is found to be necessary for amyloid-beta-induced microglial activation, and thus is thought to be an early event in Alzheimer disease pathogenesis. Mutations affecting this gene are the cause of autosomal recessive hyper-IgM immunodeficiency type 3 (HIGM3). Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Nov 2014]
Gene Info
Gene Group
"CD molecules|Tumor necrosis factor receptor superfamily"
Locus Type
gene with protein product
Location
20q13.12
Ensembl
ENSG00000101017
Associated Conditions (2)
Hyper-IgM syndrome type 3
Hyper-IgM syndrome type 1
Key Variants
RS2515708347
Conflicting classifications of pathogenicity
Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3
Health Risk
RS376780996
Conflicting classifications of pathogenicity
Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3
Health Risk
RS745435992
Conflicting classifications of pathogenicity
Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3
Health Risk
RS745496687
Conflicting classifications of pathogenicity
Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3
Health Risk
RS763263083
Conflicting classifications of pathogenicity
Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3
Health Risk
RS771363187
Conflicting classifications of pathogenicity
Health Risk
RS774195387
Conflicting classifications of pathogenicity
Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 3
Health Risk
RS775430615
Conflicting classifications of pathogenicity
Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3
Health Risk
RS776893342
Conflicting classifications of pathogenicity
Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3
Health Risk
RS886056717
Conflicting classifications of pathogenicity
Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3
Health Risk
RS1047077710
Likely pathogenic
Health Risk
RS1194453106
Likely pathogenic
Health Risk
All Variants (22)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS2515708347 | Health Risk | Conflicting classifications of pathogenicity | Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS376780996 | Health Risk | Conflicting classifications of pathogenicity | Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS745435992 | Health Risk | Conflicting classifications of pathogenicity | Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS745496687 | Health Risk | Conflicting classifications of pathogenicity | Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS763263083 | Health Risk | Conflicting classifications of pathogenicity | Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS771363187 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS774195387 | Health Risk | Conflicting classifications of pathogenicity | Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 3 |
| RS775430615 | Health Risk | Conflicting classifications of pathogenicity | Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS776893342 | Health Risk | Conflicting classifications of pathogenicity | Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS886056717 | Health Risk | Conflicting classifications of pathogenicity | Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS1047077710 | Health Risk | Likely pathogenic | — |
| RS1194453106 | Health Risk | Likely pathogenic | — |
| RS1600658150 | Health Risk | Likely pathogenic | — |
| RS2085475059 | Health Risk | Likely pathogenic | — |
| RS2515729824 | Health Risk | Likely pathogenic | — |
| RS1211645093 | Health Risk | Pathogenic | — |
| RS1460849632 | Health Risk | Pathogenic | — |
| RS1568905451 | Health Risk | Pathogenic | Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS1568906348 | Health Risk | Pathogenic | Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS2145595063 | Health Risk | Pathogenic | Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |
| RS2515708304 | Health Risk | Pathogenic | — |
| RS28931586 | Health Risk | Pathogenic | Hyper-IgM syndrome type 3, Hyper-IgM syndrome type 3 |